JYHB2400005 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Supplementary Application | 2024-01-04 | | AstraZeneca AB | | | view |
JXHB2200040 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2022-03-24 | | AstraZeneca AB | | | view |
JXHL2101261 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-11-26 | | | | | view |
JTH2300035 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Disposable Import Drug Application | 2023-02-11 | | | | | view |
JYHB2400369 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2024-07-17 | | AstraZeneca AB | | | view |
JXHS2300086 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-09-21 | | | | | view |
CYHS2101144 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(4) | Generic Drug | 2021-05-12 | | Wanbang Biopharmaceuticals | | | view |
JXHL2300321 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-12-22 | | | | | view |
JYHZ2100527 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | License Renew | 2021-04-23 | | | | | view |
JYHB2101571 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-12-09 | | AstraZeneca AB | | | view |
JYHB2101572 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-12-09 | | AstraZeneca AB | | | view |
JYHB2400368 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2024-07-17 | | AstraZeneca AB | | | view |
JYHB2300486 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Supplementary Application | 2023-08-29 | | AstraZeneca AB | | | view |
JTH2100638 | 奥希替尼薄膜衣片 | osimertinib mesylate | Tablet | Chemical Drugs | Disposable Import Drug Application | 2021-09-03 | | | | | view |
JXHB2200039 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2022-03-24 | | AstraZeneca AB | | | view |
JXHL2300320 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-12-22 | | | | | view |
JXHL2101218 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-10-28 | | | | | view |
JXHS2400042 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2024-06-21 | | | | | view |
JYHB2300485 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Supplementary Application | 2023-08-29 | | AstraZeneca AB | | | view |
JYHZ2100525 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | License Renew | 2021-04-23 | | | | | view |